Saturday, December 06, 2025 | 01:49 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Kumar Gaurav

Kumar Gaurav

Kumar Gaurav

Kumar Gaurav is a business journalist driven by a profound passion for the economy, culture, and human rights. He covers market movements, IPOs, regulatory updates, and major developments in equity markets. Having earned a Master's degree in Journalism from the University of Delhi's Delhi School of Journalism, Kumar previously worked with ET Now and Financial Express, focusing on primary and secondary markets. His dedication lies in uncovering the connections between the markets and the human experience, offering a nuanced perspective on the world of business.

Kumar Gaurav is a business journalist driven by a profound passion for the economy, culture, and human rights. He covers market movements, IPOs, regulatory updates, and major developments in equity markets. Having earned a Master's degree in Journalism from the University of Delhi's Delhi School of Journalism, Kumar previously worked with ET Now and Financial Express, focusing on primary and secondary markets. His dedication lies in uncovering the connections between the markets and the human experience, offering a nuanced perspective on the world of business.

Email
Twitter
LinkedIn

Page 4 - Kumar Gaurav

Bitcoin prices rebound following Jack Dorsey's 'Bitcoin is money' remarks

The cryptocurrency, which had fallen to around $103,598 on October 17, climbed back to $110,222 in the last 24 hours - up 2.82 per cent

Bitcoin prices rebound following Jack Dorsey's 'Bitcoin is money' remarks
Updated On : 20 Oct 2025 | 12:05 PM IST

Analysts split on LTTS post Q2FY26 results; should you buy, sell or hold?

Analysts at Choice Institutional Equities have upgraded LTTS to 'Buy' from 'Add', while Centrum Institutional Research has maintained its 'Neutral' rating on the stock

Analysts split on LTTS post Q2FY26 results; should you buy, sell or hold?
Updated On : 20 Oct 2025 | 9:58 AM IST

Here's why Nuvama trimmed Dixon Technologies' target price post Q2 results

Nuvama analysts have marginally lowered Dixon Technologies' December 2026 target price to ₹16,600 from ₹16,800, valuing the stock at 65x estimated December 2027 EPS

Here's why Nuvama trimmed Dixon Technologies' target price post Q2 results
Updated On : 20 Oct 2025 | 8:45 AM IST

Here's why Nuvama sees a strong second half for JSW Infrastructure in FY26

The brokerage has pegged a December 2026 target price of ₹360 per share, based on a 22x EV/Ebitda multiple for December 2027

Here's why Nuvama sees a strong second half for JSW Infrastructure in FY26
Updated On : 17 Oct 2025 | 10:23 AM IST

Kajaria's Q2 polish impresses, while demand cracks remain; analysts weigh

Emkay remains upbeat on Kajaria Ceramics, reiterating its Buy call, while Nuvama Institutional Equities takes a more measured stance, maintaining a Hold rating on the shares

Kajaria's Q2 polish impresses, while demand cracks remain; analysts weigh
Updated On : 17 Oct 2025 | 9:48 AM IST

Nuvama retains Buy on Hyundai India; expects steady growth with EV, hybrids

Nuvama has maintained its 'Buy' rating on Hyundai Motor India shares with a target price of ₹3,200, valuing the stock at 33x Sep-27E core EPS plus ₹119 per share in cash

Nuvama retains Buy on Hyundai India; expects steady growth with EV, hybrids
Updated On : 16 Oct 2025 | 8:37 AM IST

Paytm set to grow, says Axis Securities; upgrades to 'Buy', stock rises 3%

The analysts believe that large merchant payment providers, including Paytm, are entering a robust earnings growth phase

Paytm set to grow, says Axis Securities; upgrades to 'Buy', stock rises 3%
Updated On : 15 Oct 2025 | 1:51 PM IST

₹1.75 trillion raised in Samvat 2081: Meet the top wealth-multiplier IPOs

Top IPOs of Samvat 2081: Among the winners, Stallion India Fluorochemicals led the performance chart, with its stock rising 268 per cent from the issue price and 176 per cent above the listing price

₹1.75 trillion raised in Samvat 2081: Meet the top wealth-multiplier IPOs
Updated On : 15 Oct 2025 | 12:51 PM IST

ICICI Pru Life shares slip 3% despite healthy Q2 show; buy, sell or hold?

Market analysts attributed the decline to profit booking and sectoral pressure following the government's move to cut the Goods and Services Tax (GST) on health and life insurance products

ICICI Pru Life shares slip 3% despite healthy Q2 show; buy, sell or hold?
Updated On : 15 Oct 2025 | 10:20 AM IST

Motilal Oswal bullish on Cholamandalam Inv, sees 16% upside; here's why

Cholamandalam Investment, analysts said, is navigating a complex operating environment by reinforcing its core businesses while taking corrective measures in underperforming segments

Motilal Oswal bullish on Cholamandalam Inv, sees 16% upside; here's why
Updated On : 15 Oct 2025 | 9:19 AM IST

EPL retains 'Buy' tag from Motilal Oswal amid top-deck churn; check reasons

The analysts at MOFSL, believe that the structural and leadership changes position EPL well to drive its next growth phase

EPL retains 'Buy' tag from Motilal Oswal amid top-deck churn; check reasons
Updated On : 14 Oct 2025 | 10:36 AM IST

Signature Global sees Q2 sales slowdown, yet Nuvama says 'Buy'; here's why

The analysts believe that SGIL remains on track to achieve a net-cash status by FY27E, backed by improving collections, prudent capital deployment, and a focus on the mid-income housing segment

Signature Global sees Q2 sales slowdown, yet Nuvama says 'Buy'; here's why
Updated On : 14 Oct 2025 | 9:34 AM IST

Tata Capital debut: Emkay Global bullish on brand, diversified growth play

Tata Capital share price: The brokerage has initiated coverage on Tata Capital with an 'Add' rating and a September 2026 target price of ₹360, implying a 10 per cent upside over the issue price

Tata Capital debut: Emkay Global bullish on brand, diversified growth play
Updated On : 13 Oct 2025 | 10:15 AM IST

Motilal Oswal says 'Buy' Swiggy shares, sees 26% upside target; here's why

Swiggy's pivot from an earlier land-grab phase to a more cost-conscious operating model, analysts said, should continue to drive margin expansion and strengthen overall financial resilience

Motilal Oswal says 'Buy' Swiggy shares, sees 26% upside target; here's why
Updated On : 13 Oct 2025 | 10:13 AM IST

Brief dip, bright future: Analysts stay bullish on crypto despite retreat

The pullback in Bitcoin and Ethereum, analysts said, appears to be a short-term corrective phase within a broader bullish structure

Brief dip, bright future: Analysts stay bullish on crypto despite retreat
Updated On : 10 Oct 2025 | 2:12 PM IST

Tata Capital IPO allotment finalised; here's what GMP hints for D-St debut

Tata Capital shares are scheduled to list on exchanges on Monday, October 13, 2025. Here's what the latest grey market premium (GMP) hints at regarding the tentative listing

Tata Capital IPO allotment finalised; here's what GMP hints for D-St debut
Updated On : 10 Oct 2025 | 12:56 PM IST

LG Electronics IPO explodes with record bids: Check allotment status, GMP

LG Electronics IPO has received the highest-ever bids of ₹4.4 trillion, eclipsing the previous record held by Bajaj Housing Finance. Check share allotment status, latest GMP, tentative listing date

LG Electronics IPO explodes with record bids: Check allotment status, GMP
Updated On : 10 Oct 2025 | 8:01 AM IST

Are QIBs emerging as the new messiah of India's primary market?

QIBs, analysts suggest, have become the saviours of large offerings, especially when companies see weak demand among retail investors

Are QIBs emerging as the new messiah of India's primary market?
Updated On : 09 Oct 2025 | 6:57 AM IST

GMP buzz builds for Rubicon Research IPO: Should you apply? Reviews inside

Analysts have also shared favourable views on the IPO, boosting investor sentiment ahead of the launch of the offering

GMP buzz builds for Rubicon Research IPO: Should you apply? Reviews inside
Updated On : 08 Oct 2025 | 3:14 PM IST

Advance Agrolife delivers double-digit listing gains; book profit or hold?

Advance Agrolife share price: Advance Agrolife shares listed at ₹114 per share on the NSE, and ₹113 per share on the BSE, against the IPO issue price of ₹100 per share

Advance Agrolife delivers double-digit listing gains; book profit or hold?
Updated On : 08 Oct 2025 | 10:08 AM IST